Chimerix Inc (CMRX)
0.9068
-0.01
(-0.76%)
USD |
NASDAQ |
Nov 22, 16:00
0.9068
0.00 (0.00%)
After-Hours: 16:29
Chimerix Enterprise Value: -54.06M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -54.06M |
| November 20, 2024 | -57.09M |
| November 19, 2024 | -57.09M |
| November 18, 2024 | -57.09M |
| November 15, 2024 | -58.89M |
| November 14, 2024 | -55.40M |
| November 13, 2024 | -50.79M |
| November 12, 2024 | -46.98M |
| November 11, 2024 | -42.70M |
| November 08, 2024 | -47.19M |
| November 07, 2024 | -52.13M |
| November 06, 2024 | -45.39M |
| November 05, 2024 | -44.50M |
| November 04, 2024 | -47.19M |
| November 01, 2024 | -47.19M |
| October 31, 2024 | -48.99M |
| October 30, 2024 | -53.49M |
| October 29, 2024 | -52.59M |
| October 28, 2024 | -51.69M |
| October 25, 2024 | -57.77M |
| October 24, 2024 | -57.99M |
| October 23, 2024 | -58.93M |
| October 22, 2024 | -57.43M |
| October 21, 2024 | -57.09M |
| October 18, 2024 | -57.00M |
| Date | Value |
|---|---|
| October 17, 2024 | -57.78M |
| October 16, 2024 | -58.35M |
| October 15, 2024 | -59.86M |
| October 14, 2024 | -55.74M |
| October 11, 2024 | -56.19M |
| October 10, 2024 | -57.63M |
| October 09, 2024 | -56.20M |
| October 08, 2024 | -58.44M |
| October 07, 2024 | -54.02M |
| October 04, 2024 | -53.83M |
| October 03, 2024 | -55.29M |
| October 02, 2024 | -51.76M |
| October 01, 2024 | -56.20M |
| September 30, 2024 | -52.59M |
| September 27, 2024 | -68.18M |
| September 26, 2024 | -67.18M |
| September 25, 2024 | -72.43M |
| September 24, 2024 | -73.00M |
| September 23, 2024 | -71.66M |
| September 20, 2024 | -68.41M |
| September 19, 2024 | -69.74M |
| September 18, 2024 | -71.08M |
| September 17, 2024 | -69.34M |
| September 16, 2024 | -71.53M |
| September 13, 2024 | -71.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-137.34M
Minimum
Oct 20 2022
878.07M
Maximum
Feb 17 2021
121.92M
Average
14.02M
Median
Jan 16 2020
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.022B |
| SIGA Technologies Inc | 348.44M |
| Tonix Pharmaceuticals Holding Corp | 17.92M |
| Geovax Labs Inc | 16.88M |
| Lyell Immunopharma Inc | -184.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -22.88M |
| Revenue (Quarterly) | 0.026M |
| Total Expenses (Quarterly) | 24.82M |
| EPS Diluted (Quarterly) | -0.26 |
| Profit Margin (Quarterly) | -88.00K% |
| Earnings Yield | -104.8% |
| Normalized Earnings Yield | -104.76 |